Search Results - "Dyrda, P"

Use of infliximab within a Patient support program: positive perception of iv Infusions from Patients’ perspective by Dyrda, P, O’Reilly, R, Williamson, M, Dajnowiec, D, Jones, J, Borgaonkar, M, Siffledeen, J, Anger, D, Thompson, M

Get full text

HPR114 Formulary Management of Biologics in Plaque Psoriasis in Canada by Vannabouathong, C., Le, K., Dyrda, P.

Get full text

HPR36 Utilization of Glucagon-like Peptide-1 Receptor Agonists in Canada by Vannabouathong, C., Le, K., Dyrda, P.

Get full text

HPR144 Coverage of Biologics for Rheumatoid Arthritis in Canada by Vannabouathong, C., Le, K., Dyrda, P.

Get full text

Treatment sequence network meta-analysis in Crohn's disease: a methodological case study by Varu, Abhishek, Wilson, Florence R., Dyrda, Peter, Hazel, Maureen, Hutton, Brian, Cameron, Chris

“…Objective: Several biologic therapies are available for the treatment of mild-to-moderate Crohn's disease (CD). This network meta-analysis (NMA) aimed to…”
Get full text

PSY50 - Use of infliximab within a Patient support program: positive perception of iv Infusions from Patients’ perspective by Dyrda, P., O’Reilly, R., Williamson, M., Dajnowiec, D., Jones, J., Borgaonkar, M., Siffledeen, J., Anger, D., Thompson, M.

Get full text

A152 TREATMENT SEQUENCE NETWORK-META ANALYSIS IN CROHN’S DISEASE by Varu, A, Palimaka, S, Hutton, B, Wilson, F R, Dyrda, P, Naessens, D, Cameron, C

“…Abstract Background Crohn’s disease (CD) is a chronic inflammatory condition of the intestinal tract. There are various treatments available for CD, including…”
Get full text